China Health Insurance Sector Entering Fast Track
This article was originally published in Scrip
What health issue is keeping company managers in China up at night? According to surveys conducted among middle management, the health issue of most concern is cancer. Employees want to know how to better protect themselves and their loved ones from getting the disease or being crushed by large treatment bills.
You may also be interested in...
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.